Overview
At Innovative Biotech Solutions, we are dedicated to revolutionizing the healthcare industry with our innovative therapies targeting chronic diseases such as diabetes and cardiovascular disorders. Our team has developed a proprietary platform that enhances drug efficacy and reduces side effects through a unique biomolecular engineering approach. To date, we have successfully completed pre-clinical trials demonstrating promising results that validate our concept. As we plan to transition into clinical trials, we are seeking investment to support the next phase of our development. The funding will allow us to accelerate our research, secure necessary regulatory approvals, and streamline production processes to prepare for market entry. Our target is to launch our first product in 2028, which has the potential to impact millions of patients worldwide and significantly improve their quality of life. Our traction has been remarkable, with several partnerships established with renowned research institutions and pharmaceutical companies. We have also received positive feedback from specialists who recognize the potential of our solution in the marketplace. With our strong foundation, we n…
Use of funds
The requested €500,000 will be allocated as follows:
- R&D: €250,000 for advancing clinical trials and further research.
- Regulatory Compliance: €150,000 for securing the necessary approvals and certifications.
- Production Setup: €100,000 for establishing efficient production processes and quality control measures.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.